137 related articles for article (PubMed ID: 22228427)
1. Prognostic impact of the history of breast cancer and of hormone therapy in uterine carcinosarcoma.
Uehara T; Onda T; Togami S; Amano T; Tanikawa M; Sawada M; Ikeda S; Kato T; Kasamatsu T
Int J Gynecol Cancer; 2012 Feb; 22(2):280-5. PubMed ID: 22228427
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological characteristics, treatment and outcomes in uterine carcinosarcoma and grade 3 endometrial cancer patients: a comparative study.
Zhu J; Wen H; Bi R; Wu X
J Gynecol Oncol; 2016 Mar; 27(2):e18. PubMed ID: 26463439
[TBL] [Abstract][Full Text] [Related]
3. High Incidence of Carcinosarcoma among Patients Previously Treated with Tamoxifen.
Segev Y; Arnon E; Siegler E; Gemer O; Goldberg Y; Auslender R; Kaldawy A; Lavie O
Isr Med Assoc J; 2017 Mar; 19(3):164-167. PubMed ID: 28457094
[TBL] [Abstract][Full Text] [Related]
4. Carcinosarcoma arising in uterine didelphys after tamoxifen therapy for breast cancer: a case report.
Suprasert P; Khunamornpong S
J Med Assoc Thai; 2010 May; 93(5):608-12. PubMed ID: 20524448
[TBL] [Abstract][Full Text] [Related]
5. [Clinicopathological features of endometrial carcinoma in tamoxifen- and toremifene-treated breast cancer patients].
Otsuka I; Takahashi S; O'uchi K; Akimoto N; Hanari K; Ogaki Y; Enatsu YH; Takigawa A; Takaya H; Tanaka A; Kaseki H; Yamada T
Gan To Kagaku Ryoho; 2010 Feb; 37(2):279-83. PubMed ID: 20154485
[TBL] [Abstract][Full Text] [Related]
6. Uterine carcinosarcoma in association with tamoxifen therapy.
McCluggage WG; McManus DT; Lioe TF; Hill CM
Br J Obstet Gynaecol; 1997 Jun; 104(6):748-50. PubMed ID: 9197885
[No Abstract] [Full Text] [Related]
7. Long-term tamoxifen treatment: a possible aetiological factor in the development of uterine carcinosarcoma: two case-reports and review of the literature.
Fotiou S; Hatjieleftheriou G; Kyrousis G; Kokka F; Apostolikas N
Anticancer Res; 2000; 20(3B):2015-20. PubMed ID: 10928144
[TBL] [Abstract][Full Text] [Related]
8. [Uterine carcinosarcomas associated with tamoxifen therapy. Report of two cases and review of the literature].
Leung F; Terzibachian JJ; Govyadovskiy A; Bourtembourg A; Aouar Z; Fat BC; Maillet R; Riethmuller D
J Gynecol Obstet Biol Reprod (Paris); 2009 Apr; 38(2):173-8. PubMed ID: 19135318
[TBL] [Abstract][Full Text] [Related]
9. Tumor characteristics and survival outcomes of women with tamoxifen-related uterine carcinosarcoma.
Matsuo K; Ross MS; Bush SH; Yunokawa M; Blake EA; Takano T; Ueda Y; Baba T; Satoh S; Shida M; Ikeda Y; Adachi S; Yokoyama T; Takekuma M; Takeuchi S; Nishimura M; Iwasaki K; Yanai S; Klobocista MM; Johnson MS; Machida H; Hasegawa K; Miyake TM; Nagano T; Pejovic T; Shahzad MM; Im DD; Omatsu K; Ueland FR; Kelley JL; Roman LD
Gynecol Oncol; 2017 Feb; 144(2):329-335. PubMed ID: 27931750
[TBL] [Abstract][Full Text] [Related]
10. Uterine sarcomas in breast cancer patients treated with tamoxifen.
Arenas M; Rovirosa A; Hernández V; Ordi J; Jorcano S; Mellado B; Biete A
Int J Gynecol Cancer; 2006; 16(2):861-5. PubMed ID: 16681774
[TBL] [Abstract][Full Text] [Related]
11. Randomized comparison of tamoxifen and two separate doses of toremifene in postmenopausal patients with metastatic breast cancer.
Hayes DF; Van Zyl JA; Hacking A; Goedhals L; Bezwoda WR; Mailliard JA; Jones SE; Vogel CL; Berris RF; Shemano I
J Clin Oncol; 1995 Oct; 13(10):2556-66. PubMed ID: 7595707
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors and status of hormone receptors and angiogenic factors in uterine carcinosarcoma.
Etoh T; Nakai H
J Obstet Gynaecol Res; 2014 Mar; 40(3):820-5. PubMed ID: 24320058
[TBL] [Abstract][Full Text] [Related]
13. Carcinosarcoma, endometrial intraepithelial carcinoma and endometriosis after tamoxifen therapy in breast cancer.
Friedrich M; Villena-Heinsen C; Mink D; Bonkhoff H; Schmidt W
Eur J Obstet Gynecol Reprod Biol; 1999 Jan; 82(1):85-7. PubMed ID: 10192492
[TBL] [Abstract][Full Text] [Related]
14. Clinico-pathologic comparison of type II endometrial cancers based on tamoxifen exposure.
Tergas AI; Buell-Gutbrod R; Gwin K; Kocherginsky M; Temkin SM; Fefferman A; Lengyel E; Yamada SD
Gynecol Oncol; 2012 Nov; 127(2):316-20. PubMed ID: 22835717
[TBL] [Abstract][Full Text] [Related]
15. Uterine carcinosarcoma in association with tamoxifen therapy.
Oláh KS
Br J Obstet Gynaecol; 1997 Dec; 104(12):1420. PubMed ID: 9422027
[No Abstract] [Full Text] [Related]
16. Stage III uterine carcinosarcoma: 2009 International Federation of Gynecology and Obstetrics Staging System and Prognostic Determinants.
Garg G; Kruger M; Christensen C; Deppe G; Toy EP
Int J Gynecol Cancer; 2011 Dec; 21(9):1606-12. PubMed ID: 21720252
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors for disease-free and overall survival of patients with uterine carcinosarcoma.
Şükür YE; Taşkın S; Varlı B; Ateş C; Güngör M; Ortaç F
Int J Clin Oncol; 2018 Feb; 23(1):114-120. PubMed ID: 28836024
[TBL] [Abstract][Full Text] [Related]
18. Comparison of uterine malignancies that develop during and following tamoxifen therapy.
Ferguson SE; Soslow RA; Amsterdam A; Barakat RR
Gynecol Oncol; 2006 May; 101(2):322-6. PubMed ID: 16352333
[TBL] [Abstract][Full Text] [Related]
19. Tamoxifen-related uterine carcinosarcomas occur under/after prolonged treatment: report of five cases and review of the literature.
Kloos I; Delaloge S; Pautier P; Di Palma M; Goupil A; Duvillard P; Cailleux PE; Lhomme C
Int J Gynecol Cancer; 2002; 12(5):496-500. PubMed ID: 12366669
[TBL] [Abstract][Full Text] [Related]
20. Clinico-pathology and prognosis of endometrial cancer in patients previously treated for breast cancer, with or without tamoxifen: a comparative study in 363 patients.
Ngô C; Brugier C; Plancher C; de la Rochefordière A; Alran S; Féron JG; Malhaire C; Scholl S; Sastre X; Rouzier R; Fourchotte V;
Eur J Surg Oncol; 2014 Oct; 40(10):1237-44. PubMed ID: 25086993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
